Prescription drug · ANDA
Deflazacort NDC 73190-068
Deflazacort 6 mg/1 · Tablet · Oral · AvKARE
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73190-068-01 | 73190006801 | 1 BOTTLE in 1 CARTON (73190-068-01) / 100 TABLET in 1 BOTTLEMarketed from Dec 10, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Deflazacort
- Generic name (nonproprietary)
- deflazacort
- Active ingredients
- Deflazacort — 6 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- AvKARE
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 219254
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 73190-068_459b75af-2b59-2f1e-e063-6394a90a9ed4SPL ID 459b75af-2b59-2f1e-e063-6394a90a9ed4SPL set ID 459b75a2-3242-3048-e063-6394a90ab882RxCUI 153098, 153880, 1870954, 1870958UNII KR5YZ6AE4B
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473190006801followed by a unit qualifier and the quantityPackage 73190-0068-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Deflazacort tablets are indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older. Additional pediatric use information is approved for PTC Therapeutics, Inc.'s Emflaza™ (deflazacort) tablets. However, due to PTC Therapeutics, Inc.'s marketing exclusivity rights, this drug product is not labeled with that information. Deflazacort tablets are a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 219254
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Deflazacort | Deflazacort 30 mg/1 | TabletOral | AvKARE | 73190-070 |
| Deflazacort | Deflazacort 18 mg/1 | TabletOral | AvKARE | 73190-069 |
| Deflazacort | Deflazacort 36 mg/1 | TabletOral | AvKARE | 73190-071 |
| Jaytharideflazacort | Deflazacort 18 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-175 |
| Deflazacort | Deflazacort 6 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-2051 |
| Jaytharideflazacort | Deflazacort 6 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-174 |
| Jaytharideflazacort | Deflazacort 30 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-176 |
| Deflazacort | Deflazacort 18 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-2052 |
| Deflazacort | Deflazacort 30 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-2053 |
| Jaytharideflazacort | Deflazacort 36 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-177 |
| Deflazacort | Deflazacort 36 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-2054 |
| Deflazacort | Deflazacort 36 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-208 |
| Deflazacort | Deflazacort 6 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-204 |
| Deflazacort | Deflazacort 18 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-206 |
| Deflazacort | Deflazacort 30 mg/1 | TabletOral | Doppel Farmaceutici S.r.l. | 81806-207 |
| Jaytharideflazacort | Deflazacort 36 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1752 |
| Jaytharideflazacort | Deflazacort 6 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1749 |
| Jaytharideflazacort | Deflazacort 18 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1750 |
| Jaytharideflazacort | Deflazacort 30 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1751 |